| 08:30 - 10:30 | 24 | Pharmacoepidemiology of obstructive lung disease: beyond clinical trials | Major Symposium |
| 08:30 - 10:30 | 25 | Clinical year in review | Hot topics |
| 08:30 - 10:30 | 26 | Cellular and molecular strategies to repair the damaged lung | Major Symposium |
| 08:30 - 10:30 | 27 | Noninvasive ventilation for respiratory failure in obese patients | Assembly Symposium |
| 08:30 - 10:30 | 28 | Pulmonary hypertension | Oral Presentation |
| 08:30 - 10:30 | 29 | A new approach to the detection of latent tuberculosis infection (LTBI) | Assembly Symposium |
| 08:30 - 10:30 | 30 | Functional insights: lung and respiratory muscle | Oral Presentation |
| 08:30 - 10:30 | 31 | Lung development and cancer | Oral Presentation |
| 08:30 - 10:30 | 32 | Modulation of the allergic response in animal models | Oral Presentation |
| 08:30 - 10:30 | 33 | Occupational asthma: epidemiology, risk factors, outcome | Oral Presentation |
| 08:30 - 10:30 | 34 | Community acquired pneumonia - epidemiology and host defence | Oral Presentation |
| 08:30 - 10:30 | 35 | Pathobiological and clinical investigations in interstitial lung diseases | Oral Presentation |
| 08:30 - 10:30 | 36 | Assessment of lung function before resection of lung cancer | Oral Presentation |
| 08:30 - 10:30 | 37 | Clinical and behavioural consequences of COPD | Poster Discussion |
| 08:30 - 10:30 | 38 | Practical issues in the management of childhood asthma | Poster Discussion |
| 10:45 - 12:45 | 39 | Weaning and noninvasive mechanical ventilation (NIV) | Major Symposium |
| 10:45 - 12:45 | 40 | Clinical Grand Round, an interactive session | Major Symposium |
| 10:45 - 12:45 | 42 | The First European Respiratory Meeting, 50 years on | Symposium |
| 10:45 - 12:45 | 43 | Improved understanding of the basic mechanisms impact on the management of COPD | Oral Presentation |
| 10:45 - 12:45 | 45 | Highlights of risk factors for asthma | Oral Presentation |
| 10:45 - 12:45 | 46 | Viral bronchiolitis in children: what's new in diagnosis and treatment? | Oral Presentation |
| 10:45 - 12:45 | 47 | Pneumothorax, chest drains | Oral Presentation |
| 10:45 - 12:45 | 48 | New tools and new concepts in respiratory monitoring | Oral Presentation |
| 10:45 - 12:45 | 49 | Update on smoking related damage and cessation | Oral Presentation |
| 10:45 - 12:45 | 50 | Cellular injury and repair in the lung | Oral Presentation |
| 10:45 - 12:45 | 51 | Exercise and systemic effects in COPD | Oral Presentation |
| 10:45 - 12:45 | 52 | Diagnostic clinical and biological features in tuberculosis | Poster Discussion |
| 10:45 - 12:45 | 53 | Inflammation and tissue repair in pulmonary disease | Poster Discussion |
| 10:45 - 12:45 | 54 | Treatment of lung cancer and lung metastases | Poster Discussion |
| 10:45 - 12:45 | 55 | Advancements in pathobiology of respiratory diseases | Poster Discussion |
| 13:00 - 14:00 | 74 | MP14 - Enlarged paratracheal lymph nodes: from medical imaging to positive diagnosis | Meet the Professor |
| 13:30 - 15:30 | 79 | "Chronic cough, hyperreactivity and lung granuloma""s""" | Thematic Poster Session |
| 13:30 - 15:30 | 80 | Infectious pneumonia and related diseases including tuberculosis | Thematic Poster Session |
| 13:30 - 15:30 | 81 | Pulmonary and respiratory pump function | Thematic Poster Session |
| 13:30 - 15:30 | 82 | Complications and prognosis of COPD | Thematic Poster Session |
| 13:30 - 15:30 | 83 | Biological correlates of COPD | Thematic Poster Session |
| 13:30 - 15:30 | 84 | Acute and chronic management of COPD | Thematic Poster Session |
| 13:30 - 15:30 | 85 | Imaging in COPD, pulmonary embolism and other pulmonary vascular disorders | Thematic Poster Session |
| 13:30 - 15:30 | 86 | Diagnostic techniques in pulmonary and pleural diseases | Thematic Poster Session |
| 13:30 - 15:30 | 87 | Complications of lung cancer or its treatment quality of life - prognosis | Thematic Poster Session |
| 13:30 - 15:30 | 88 | Molecular biology and tumoral markers | Thematic Poster Session |
| 13:30 - 15:30 | 89 | Pathobiology in experimental and neoplastic lung diseases | Thematic Poster Session |
| 13:30 - 15:30 | 90 | Primary care: asthma, allergy and COPD | Thematic Poster Session |
| 13:30 - 15:30 | 91 | Primary care: COPD | Thematic Poster Session |
| 13:30 - 15:30 | 92 | Treatment and outcome of acute respiratory failure | Thematic Poster Session |
| 13:30 - 15:30 | 93 | Pathogenesis of asthma and COPD | Thematic Poster Session |
| 13:30 - 15:30 | 94 | Epithelial cells in inflammatory airway disease | Thematic Poster Session |
| 13:30 - 15:30 | 95 | Animal models of lung injury and repair | Thematic Poster Session |
| 13:30 - 15:30 | 96 | In-vitro analysis of cellular response to lung injury | Thematic Poster Session |
| 13:30 - 15:30 | 97 | Pulmonary hypertension | Thematic Poster Session |
| 13:30 - 15:30 | 98 | Clinical aspects of OSA | Thematic Poster Session |
| 13:30 - 15:30 | 99 | Diagnosis of OSA | Thematic Poster Session |
| 13:30 - 15:30 | 100 | COPD: insights from structure and function | Thematic Poster Session |
| 13:30 - 15:30 | 101 | Current treatments for allergic rhinitis and asthma | Thematic Poster Session |
| 13:30 - 15:30 | 102 | Exploring new basic aspects of treatment of asthma | Thematic Poster Session |
| 13:30 - 15:30 | 103 | Therapy in asthma and COPD | Thematic Poster Session |
| 13:30 - 15:30 | 104 | Genetics and epidemiology in respiratory studies - adults and children | Thematic Poster Session |
| 13:30 - 15:30 | 105 | Asthma and allergy: prevalence and risk factors | Thematic Poster Session |
| 13:30 - 15:30 | 106 | Quality of life and morbidity aspects in COPD | Thematic Poster Session |
| 13:30 - 15:30 | 107 | Pneumoconioses and interstitial occupational lung disease | Thematic Poster Session |
| 13:30 - 15:30 | 108 | Various exposures | Thematic Poster Session |
| 13:30 - 15:30 | 109 | Tobacco smoking and respiratory disease | Thematic Poster Session |
| 13:30 - 15:30 | 110 | Smoking cessation: assessment and management | Thematic Poster Session |
| 13:30 - 15:30 | 111 | Clinical questions being answered by paediatric lung function | Thematic Poster Session |
| 13:30 - 15:30 | 112 | Mechanisms in allergic diseases | Thematic Poster Session |
| 13:30 - 15:30 | 113 | Therapy in paediatric asthma I | Thematic Poster Session |
| 13:30 - 15:30 | 114 | Paediatric respiratory epidemiology I | Thematic Poster Session |
| 13:30 - 15:30 | 115 | Trauma, interstitial disease and miscellaneous | Thematic Poster Session |
| 13:30 - 15:30 | 116 | Trachea, mediastinum and rare tumours | Thematic Poster Session |
| 13:30 - 15:30 | 117 | Lung transplantation: update on clinical and experimental issues | Thematic Poster Session |
| 13:30 - 15:30 | 118 | Standardization of tests and equipment evaluation: from spirometry on wards | Thematic Poster Session |
| 13:30 - 15:30 | 119 | Community acquired pneumonia | Thematic Poster Session |
| 13:30 - 15:30 | 120 | Epidemiology of tuberculosis I | Thematic Poster Session |
| 13:30 - 15:30 | 121 | Epidemiology of tuberculosis II | Thematic Poster Session |
| 13:30 - 15:30 | 122 | Epidemiology of tuberculosis and HIV co-infection | Thematic Poster Session |
| 13:30 - 15:30 | 123 | Clinical and related features in tuberculosis | Thematic Poster Session |
| 14:45 - 16:45 | 124 | Update on rare diffuse lung diseases | Major Symposium |
| 14:45 - 16:45 | 125 | Lung metastases | Major Symposium |
| 14:45 - 16:45 | 126 | ISAAC and ECRHS - What have they taught us? | Assembly Symposium |
| 14:45 - 16:45 | 127 | Smoking and asthma | Hot topics |
| 14:45 - 16:45 | 128 | Pulmonary hypertension | Oral Presentation |
| 14:45 - 16:45 | 129 | Proteinase-activated receptors (PARs) - sentries for lung inflammation and fibrosis | Assembly Symposium |
| 14:45 - 16:45 | 130 | The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research | Oral Presentation |
| 14:45 - 16:45 | 131 | Clinical and diagnostic features of tuberculosis | Oral Presentation |
| 14:45 - 16:45 | 132 | CPAP therapy for OSA | Oral Presentation |
| 14:45 - 16:45 | 133 | Outcome of pulmonary rehabilitation | Oral Presentation |
| 14:45 - 16:45 | 134 | Immunology of airway and pulmonary disease | Oral Presentation |
| 14:45 - 16:45 | 135 | New aspects of drug therapy in paediatric asthma | Oral Presentation |
| 14:45 - 16:45 | 136 | Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems | Oral Presentation |
| 14:45 - 16:45 | 137 | Exercise in COPD | Poster Discussion |
| 14:45 - 16:45 | 138 | New and emerging pharmacological strategies in the treatment of asthma | Poster Discussion |
| 14:45 - 16:45 | 139 | Interactions between pulmonary physiology and general medicine | Poster Discussion |
| 17:15 - 19:15 | 145 | Early management of inflammatory airway diseases - Can we do better? | Evening Symposium |
| 17:15 - 19:15 | 147 | Developments in the management of lower respiratory tract infections | Evening Symposium |
| 17:15 - 19:15 | 148 | Alpha-1-antitrypsin deficiency: Current knowledge and new frontiers | Evening Symposium |